Calliditas Therapeutics AB (NAS:CALT)
$ 40.0001 -0.1599 (-0.4%) Market Cap: 1.08 Bil Enterprise Value: 1.10 Bil PE Ratio: 0 PB Ratio: 104.30 GF Score: 33/100

Q3 2021 Calliditas Therapeutics AB Earnings Call Transcript

Nov 18, 2021 / 01:30PM GMT
Release Date Price: $17.7 (+6.88%)
Operator

Hello, and welcome to Calliditas Therapeutics Conference Call for Q3 2021. (Operator Instructions) Just to remind you, this conference call is being recorded. Today, I am pleased to present our first speaker of today, CEO, Renee Lucander. Please go ahead.

Renee Aguiar;Lucander;publ;CEO
Calliditas Therapeutics AB

()-

Thank you, and welcome to this Q3 presentation. I am joined today by Richard Philipson, our Chief Medical Officer; Fredrik Johansson, our Chief Financial Officer; and Andy Udell, President, North America. Before we launch into the report, I just want to draw your attention to the disclaimer page, on Page 2, related to any forward-looking statements and refer you to the disclosures made in company filings with the SEC.

So on Page 3, some highlights from the quarter. During this quarter, we concluded transactions aimed at progressing our established partnering strategy ex-U.S. and also to strengthen our cash position. So after a broad and successful structured process in the -- during the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot